Pharmaxis Ltd's oversubscribed share purchase plan raises $2.6 million
The clinical-stage drug development company opted to increase its raise target from A$2 million after receiving eligible applications for...
Source: proactiveinvestors.com.au
Page 15 - Pharmaxis Ltd News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Pharmaxis Ltd. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Pharmaxis Ltd Today - Breaking & Trending Today
Pharmaxis Ltd stocks rising with new drugs coming online in 2022, says broker
Among a range of factors for the outperform recommendation, Taylor Collison cites the company’s two FDA-approved respiratory products,...
Source: proactiveinvestors.com.au
EffRx Pharmaceuticals: EffRx Obtains Swiss Marketing Authorization for Bronchitol in Cystic Fibrosis
EffRx Pharmaceuticals SA, a commercial-stage company that commercializes niche and orphan medicines in Switzerland and Europe, today announced that Swissmedic has approved Bronchitol (inhaled mannitol)
Source: finanznachrichten.de
Pharmaxis welcomes green light to progress to Phase 2 bone marrow cancer trial
Pharmaxis Ltd's Gary Phillips speaks to Proactive following the news they've been cleared to progress its bone marrow cancer trial to a phase 2 dose...
Source: proactiveinvestors.com
Pharmaxis Cleared To Progress To Phase 2 Bone Marrow Cancer Trial
/PRNewswire/ -- Clinical stage drug development company Pharmaxis Ltd (ASX: PXS) today announced further positive results of data analysis from a phase 1c...
Source: prnewswire.com